ABVD regimen
WikiDoc Resources for ABVD regimen |
Articles |
---|
Most recent articles on ABVD regimen Most cited articles on ABVD regimen |
Media |
Powerpoint slides on ABVD regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on ABVD regimen at Clinical Trials.gov Clinical Trials on ABVD regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on ABVD regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on ABVD regimen Discussion groups on ABVD regimen Patient Handouts on ABVD regimen Directions to Hospitals Treating ABVD regimen Risk calculators and risk factors for ABVD regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for ABVD regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: ABVD; ABVD regimen; Adriamycin-Bleomycin-Vinblastine-Dacarbazine regimen; BLEO/DOX/DTIC/VBL; Bleomycin/Dacarbazine/Doxorubicin/Vinblastine regimen
Overview
ABVD regimen refers to an a chemotherapy regimen consisting of doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine and dacarbazine, used alone or in combination with radiation therapy, for the primary treatment of Hodgkin lymphoma.[1][2]
Regimen
ADoxorubicin (Adriamycin)
BBleomycin
VVinblastine
DDacarbazine
Indications
- Primary treatment of Hodgkin's lymphoma [3]
References
- ↑ "NCI Thesaurus".
- ↑ "R-CHOP - National Cancer Institute".
- ↑ Nagai H (2014). "[Hodgkin lymphoma]". Nihon Rinsho. 72 (6): 1099–103. PMID 25016811.